| 1029 | HSAP00P0000193465 | -1.499 | 8.209 | -4.572 | 0.0003235 | 0.01162 | 0.3093 | CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | ENSG00000147889 | 151623, 155601, 155755, 600160, 606719 | 1029 | BC015960 |
| 1063 | HSAP00P0000039968 | -1.601 | 6.615 | -3.507 | 0.002973 | 0.04772 | -1.845 | CENPF | centromere protein F, 350/400kDa (mitosin) | ENSG00000117724 | 600236 | 1063 | NM_016343 |
| 2033 | HSAP00P0000417540 | -0.5073 | 8.841 | -1.538 | 0.1438 | 0.4187 | -5.403 | EP300 | E1A binding protein p300 | ENSG00000100393 | 114500, 180849, 602700, 613684 | 2033 | U01877 |
| 207 | HSAP00P0000298189 | -1.597 | 9.721 | -6.938 | 3.59e-06 | 0.0007116 | 4.692 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ENSG00000142208 | 114480, 114500, 164730, 167000, 176920, 181500, 604370 | 207 | NM_005163 |
| 2175 | HSAP00P0000332720 | 1.04 | 8.665 | 2.44 | 0.0269 | 0.1766 | -3.928 | FANCA | Fanconi anemia, complementation group A | ENSG00000187741 | 227650, 607139 | 2175 | NM_000135 |
| 2176 | HSAP00P0000199718 | 0.3474 | 8.841 | 1.385 | 0.1853 | 0.4725 | -5.607 | FANCC | Fanconi anemia, complementation group C | ENSG00000158169 | 227645, 227650, 613899 | 2176 | NM_000136 |
| 2885 | HSAP00P0000354354 | -0.7753 | 7.577 | -2.416 | 0.02821 | 0.1814 | -3.971 | GRB2 | growth factor receptor-bound protein 2 | ENSG00000177885 | 108355 | 2885 | NM_002086 |
| 2886 | HSAP00P0000344234 | -1.117 | 5.137 | -2.555 | 0.02135 | 0.1551 | -3.714 | GRB7 | growth factor receptor-bound protein 7 | ENSG00000141738 | 601522 | 2886 | NM_005310 |
| 3014 | HSAP00P0000251542 | -1.349 | 8.635 | -4.419 | 0.0004434 | 0.01422 | 0.001731 | H2AFX | H2A histone family, member X | ENSG00000188486 | 601772 | 3014 | NM_002105 |
| 3065 | HSAP00P0000010163 | -1.212 | 10.6 | -3.593 | 0.002477 | 0.04269 | -1.669 | HDAC1 | histone deacetylase 1 | ENSG00000116478 | 601241 | 3065 | NM_004964 |
| 3066 | HSAP00P0000149822 | -1.926 | 8.656 | -5.61 | 4.108e-05 | 0.003162 | 2.325 | HDAC2 | histone deacetylase 2 | ENSG00000196591 | 605164 | 3066 | NM_001527 |
| 3159 | HSAP00P0000141202 | -2.174 | 8.815 | -6.567 | 6.919e-06 | 0.001045 | 4.057 | HMGA1 | high mobility group AT-hook 1 | ENSG00000137309 | 125853, 600701 | 3159 | AK130027 |
| 4691 | HSAP00P0000070997 | -3.368 | 8.67 | -7.59 | 1.185e-06 | 0.0003677 | 5.756 | NCL | nucleolin | ENSG00000115053 | 164035 | 4691 | AK091742 |
| 4869 | HSAP00P0000130260 | -3.315 | 12.2 | -9.861 | 3.768e-08 | 4.695e-05 | 8.996 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | ENSG00000181163 | 164040, 601626 | 4869 | AY347529 |
| 580 | HSAP00P0000068169 | -2.589 | 9.625 | -8.77 | 1.83e-07 | 0.0001189 | 7.527 | BARD1 | BRCA1 associated RING domain 1 | ENSG00000138376 | 114480, 601593 | 580 | NM_000465 |
| 672 | HSAP00P0000346604 | -0.8625 | 7.493 | -2.238 | 0.04001 | 0.2194 | -4.29 | BRCA1 | breast cancer 1, early onset | ENSG00000012048 | 113705, 114480, 604370 | 672 | AF005068 |